BioStock: New proposal potential game changer for Adjutec Pharma
A group of experts from the DRIVE-AB project has introduced a new plan to boost the fight against antimicrobial resistance in the EU and EEA. This pan-European proposal aims to establish a strong incentive model for the development and accessibility of new antimicrobials — a move that could provide support for drug developers like Norwegian Adjutec Pharma.Read the full article at biostock.se : https://www.biostock.se/en/2024/01/new-proposal-potential-game-changer-for-adjutec-pharma/ This is a press release from BioStock - Connecting Innovation & Capital.